Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI
- Study Title
- A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
- Teva Identifier
- ABS-AS-101
- ClinicalTrials.gov Identifier
- NCT01056159
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 45 Years
- Trial Duration
- 01/01/2010 - 06/01/2010
- Phase
- Phase 1